View in EDS HTML Full Text PDF Full Text

Clinical Differences Between Inpatients With and Without Alexithymia in Substance Use Disorder Treatment.

Saved in:
Bibliographic Details
Title: Clinical Differences Between Inpatients With and Without Alexithymia in Substance Use Disorder Treatment.
Authors: Remacle, Florine (AUTHOR), Kempeneers, Philippe (AUTHOR), Mreyen, Kristina (AUTHOR), Pallincourt, Romain (AUTHOR), Simon, Jessica (AUTHOR), Wildemeersch, Géraldine (AUTHOR)
Source: Substance Use & Misuse. 2026, Vol. 61 Issue 8, p1268-1276. 9p.
Subjects: Substance abuse treatment, Emotion regulation, Self-esteem testing, Statistical power analysis, Repeated measures design, Self-efficacy, Center for Epidemiologic Studies Depression Scale, Research funding, Alexithymia, Hospital care, Questionnaires, Hospital patients, Severity of illness index, Anxiety, Emotions, Rumination (Cognition), Confidence, Desire, Motivation (Psychology), State-Trait Anxiety Inventory, Psychological stress, Analysis of variance, Belgians, Psychiatric hospitals, Psychological tests, Mental depression, Self-perception
Abstract: Background: This study investigates the clinical evolution of Belgian individuals following an inpatient treatment for substance use disorder (SUD), based on the presence or absence of alexithymia, as defined by difficulties in emotional identification and expression. Objectives: The objective of this study was to examine differences in clinical evolution during inpatient SUD treatment between individuals with high versus low levels of alexithymia. Among 119 inpatients, 92 were classified into two groups based on TAS-20 scores: a high-alexithymia group (n1 = 51, 42.86%, TAS-20 > 60) and a low-alexithymia group (n2 = 41, 34.45%, TAS-20 < 52). Clinical assessments were conducted at baseline, during the first week of hospitalization, and then at 2 weeks (n1 = 35, n2 = 29), and after 4 weeks of treatment (n1 = 24, n2 = 14). Results: At baseline, high alexithymia scores were associated with higher anxiety, emotional reactivity, and depressive symptoms. However, differences in addiction-related indicators, such as craving and self-efficacy, were less pronounced. All patients showed improvements in clinical symptoms during treatment, particularly in perceived stress and ruminations, but those with high alexithymia retained higher symptom severity. While both groups reported similar levels of craving, patients with alexithymia appeared to struggle more with emotional regulation. Conclusions: These findings suggest that alexithymia may negatively impact emotional regulation during SUD treatment and potentially affect long-term recovery. The results highlight the need for increased interventions that enhance emotional processing in individuals with alexithymia. Limitations include the small sample size and reliance on self-report measures, which may affect generalizability. Overall, this research enhances understanding of alexithymia's contribution to SUD treatment and supports the necessity for tailored therapeutic approaches, warranting further investigation into long-term effects and specific interventions for alexithymic traits. [ABSTRACT FROM AUTHOR]
Copyright of Substance Use & Misuse is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 193623167
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical Differences Between Inpatients With and Without Alexithymia in Substance Use Disorder Treatment.
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Remacle%2C+Florine%22&quot;&gt;Remacle, Florine&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Kempeneers%2C+Philippe%22&quot;&gt;Kempeneers, Philippe&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Mreyen%2C+Kristina%22&quot;&gt;Mreyen, Kristina&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Pallincourt%2C+Romain%22&quot;&gt;Pallincourt, Romain&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Simon%2C+Jessica%22&quot;&gt;Simon, Jessica&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Wildemeersch%2C+G&#233;raldine%22&quot;&gt;Wildemeersch, G&#233;raldine&lt;/searchLink&gt; (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: &lt;searchLink fieldCode=&quot;JN&quot; term=&quot;%22Substance+Use+%26+Misuse%22&quot;&gt;Substance Use &amp; Misuse&lt;/searchLink&gt;. 2026, Vol. 61 Issue 8, p1268-1276. 9p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Substance+abuse+treatment%22&quot;&gt;Substance abuse treatment&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Emotion+regulation%22&quot;&gt;Emotion regulation&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Self-esteem+testing%22&quot;&gt;Self-esteem testing&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Statistical+power+analysis%22&quot;&gt;Statistical power analysis&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Repeated+measures+design%22&quot;&gt;Repeated measures design&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Self-efficacy%22&quot;&gt;Self-efficacy&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Center+for+Epidemiologic+Studies+Depression+Scale%22&quot;&gt;Center for Epidemiologic Studies Depression Scale&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Research+funding%22&quot;&gt;Research funding&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Alexithymia%22&quot;&gt;Alexithymia&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Hospital+care%22&quot;&gt;Hospital care&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Questionnaires%22&quot;&gt;Questionnaires&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Hospital+patients%22&quot;&gt;Hospital patients&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Severity+of+illness+index%22&quot;&gt;Severity of illness index&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Anxiety%22&quot;&gt;Anxiety&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Emotions%22&quot;&gt;Emotions&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Rumination+%28Cognition%29%22&quot;&gt;Rumination (Cognition)&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Confidence%22&quot;&gt;Confidence&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Desire%22&quot;&gt;Desire&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Motivation+%28Psychology%29%22&quot;&gt;Motivation (Psychology)&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22State-Trait+Anxiety+Inventory%22&quot;&gt;State-Trait Anxiety Inventory&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Psychological+stress%22&quot;&gt;Psychological stress&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Analysis+of+variance%22&quot;&gt;Analysis of variance&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Belgians%22&quot;&gt;Belgians&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Psychiatric+hospitals%22&quot;&gt;Psychiatric hospitals&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Psychological+tests%22&quot;&gt;Psychological tests&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Mental+depression%22&quot;&gt;Mental depression&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Self-perception%22&quot;&gt;Self-perception&lt;/searchLink&gt;
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background: This study investigates the clinical evolution of Belgian individuals following an inpatient treatment for substance use disorder (SUD), based on the presence or absence of alexithymia, as defined by difficulties in emotional identification and expression. Objectives: The objective of this study was to examine differences in clinical evolution during inpatient SUD treatment between individuals with high versus low levels of alexithymia. Among 119 inpatients, 92 were classified into two groups based on TAS-20 scores: a high-alexithymia group (n1 = 51, 42.86%, TAS-20 &gt; 60) and a low-alexithymia group (n2 = 41, 34.45%, TAS-20 &lt; 52). Clinical assessments were conducted at baseline, during the first week of hospitalization, and then at 2 weeks (n1 = 35, n2 = 29), and after 4 weeks of treatment (n1 = 24, n2 = 14). Results: At baseline, high alexithymia scores were associated with higher anxiety, emotional reactivity, and depressive symptoms. However, differences in addiction-related indicators, such as craving and self-efficacy, were less pronounced. All patients showed improvements in clinical symptoms during treatment, particularly in perceived stress and ruminations, but those with high alexithymia retained higher symptom severity. While both groups reported similar levels of craving, patients with alexithymia appeared to struggle more with emotional regulation. Conclusions: These findings suggest that alexithymia may negatively impact emotional regulation during SUD treatment and potentially affect long-term recovery. The results highlight the need for increased interventions that enhance emotional processing in individuals with alexithymia. Limitations include the small sample size and reliance on self-report measures, which may affect generalizability. Overall, this research enhances understanding of alexithymia&#39;s contribution to SUD treatment and supports the necessity for tailored therapeutic approaches, warranting further investigation into long-term effects and specific interventions for alexithymic traits. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: &lt;i&gt;Copyright of Substance Use &amp; Misuse is the property of Taylor &amp; Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder&#39;s express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=193623167
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10826084.2025.2604210
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 1268
    Subjects:
      – SubjectFull: Substance abuse treatment
        Type: general
      – SubjectFull: Emotion regulation
        Type: general
      – SubjectFull: Self-esteem testing
        Type: general
      – SubjectFull: Statistical power analysis
        Type: general
      – SubjectFull: Repeated measures design
        Type: general
      – SubjectFull: Self-efficacy
        Type: general
      – SubjectFull: Center for Epidemiologic Studies Depression Scale
        Type: general
      – SubjectFull: Research funding
        Type: general
      – SubjectFull: Alexithymia
        Type: general
      – SubjectFull: Hospital care
        Type: general
      – SubjectFull: Questionnaires
        Type: general
      – SubjectFull: Hospital patients
        Type: general
      – SubjectFull: Severity of illness index
        Type: general
      – SubjectFull: Anxiety
        Type: general
      – SubjectFull: Emotions
        Type: general
      – SubjectFull: Rumination (Cognition)
        Type: general
      – SubjectFull: Confidence
        Type: general
      – SubjectFull: Desire
        Type: general
      – SubjectFull: Motivation (Psychology)
        Type: general
      – SubjectFull: State-Trait Anxiety Inventory
        Type: general
      – SubjectFull: Psychological stress
        Type: general
      – SubjectFull: Analysis of variance
        Type: general
      – SubjectFull: Belgians
        Type: general
      – SubjectFull: Psychiatric hospitals
        Type: general
      – SubjectFull: Psychological tests
        Type: general
      – SubjectFull: Mental depression
        Type: general
      – SubjectFull: Self-perception
        Type: general
    Titles:
      – TitleFull: Clinical Differences Between Inpatients With and Without Alexithymia in Substance Use Disorder Treatment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Remacle, Florine
      – PersonEntity:
          Name:
            NameFull: Kempeneers, Philippe
      – PersonEntity:
          Name:
            NameFull: Mreyen, Kristina
      – PersonEntity:
          Name:
            NameFull: Pallincourt, Romain
      – PersonEntity:
          Name:
            NameFull: Simon, Jessica
      – PersonEntity:
          Name:
            NameFull: Wildemeersch, Géraldine
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 10826084
          Numbering:
            – Type: volume
              Value: 61
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Substance Use & Misuse
              Type: main
ResultId 1